News and Events

Participation in longitudinal surveillance programme associated with thinner melanomas for members of melanoma-prone families

10 April 2021

Skin cancer screening is routinely performed for members of melanoma-prone families. The prupose of this recent study was to evaluate the efficacy of surveillance. The study concludes that participation in a longitudinal surveillance programme providing skin cancer screening and education about skin self-exams was associated with thinner melanomas for members of melanoma-prone families.

Impact of shave biopsy on diagnosis and management of cutaneous melanoma

9 April 2021

According to this recent study, just over 40% of melanomas diagnosed on shave biopsy report a positive deep margin; however, this translated into a change in tumor stage or treatment recommendations in relatively few patients (7.7% and 2.3%, respectively), with no impact on local recurrence or survival among the studies analyzed.

Regression a favorable prognostic factor for stage 1 or 2 melanoma patients, especially in those with thin and intermediate thickness melanomas and superficial spreading melanomas

8 April 2021

The objective of this recent study was to determine whether histologically confirmed regression was associated with better or worse survival in patients with primary cutaneous melanoma. The study concludes that regression was a favorable prognostic factor for patients with stage 1 and 2 melanomas, especially in those with thin and intermediate thickness tumors and those with  superficial spreading melanoma (SSM) subtype.